FDA Approved: ELZONRIS — Supplemental Application (Stemline Therapeutics, Inc.)

View source ↗

Summary

FDA has approved a supplemental application for ELZONRIS (tagraxofusp) submitted by Stemline Therapeutics, Inc., reflecting an update to its labeling or indicat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Blastic Plasmacytoid Dendritic Cell Neoplasm

Drugs mentioned

• Elzonris (tagraxofusp)

Snippet

SUPPL AP for ELZONRIS (TAGRAXOFUSP)